Atualização no Tratamento da Hipertensão Arterial Pulmonar-Reference-Cited by-同舟云学术

Atualização no Tratamento da Hipertensão Arterial Pulmonar

Published:2021-10 Issue:4 Volume:117 Page:750-764
ISSN:0066-782X
Container-title:Arquivos Brasileiros de Cardiologia
language:en
Short-container-title:

Author:

Fernandes Caio J.^ORCID,Calderaro Daniela^ORCID,Assad Ana Paula Luppino,Salibe-Filho William,Kato-Morinaga Luciana Tamie,Hoette Susana,Piloto Bruna,Castro Marcela Araújo^ORCID,Lisboa Roberta Pontes,Silva Taysa Antonia Felix da,Martins Murillo de Araújo,Alves-Jr Jose L.,Jardim Carlos,Terra-Filho Mario,Souza Rogerio de

Publisher

Sociedade Brasileira de Cardiologia

Subject

Cardiology and Cardiovascular Medicine

Reference122 articles.

1. Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Pathophysiology;Humbert;Eur Respir Rev,2010

2. Pulmonary Hypertension: Definition, Classification, and Diagnosis;Alves;Semin Respir Crit Care Med,2017

3. A global View of Pulmonary Hypertension;Hoeper;Lancet Respir Med,2016

4. Survival in Patients with Primary Pulmonary Hypertension. Results from a National Prospective Registry;D’Alonzo;Ann Intern Med,1991

5. Goal-Oriented Treatment of Pulmonary Arterial Hypertension;Jardim;Curr Opin Pulm Med,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Melatonin effects on oxidative stress and on TLR4/NF-kβ inflammatory pathway in the right ventricle of rats with pulmonary arterial hypertension;Molecular and Cellular Endocrinology;2024-10

2. Schistosomiasis: A neglected cause of pulmonary arterial hypertension in Brazil;Current Problems in Cardiology;2024-03

3. Pharmacological Agents and Potential New Therapies in Pulmonary Arterial Hypertension;Current Vascular Pharmacology;2023-12-19

4. Unusual Forms of Pulmonary Hypertension;Heart Failure Clinics;2023-01

5. Why Multitarget Vasodilatory (Endo)cannabinoids Are Not Effective as Antihypertensive Compounds after Chronic Administration: Comparison of Their Effects on Systemic and Pulmonary Hypertension;Pharmaceuticals;2022-09-07